BioCentury
ARTICLE | Company News

Oryx, Novartis deal

September 9, 2002 7:00 AM UTC

Specialty pharma company Oryx acquired Canadian rights to NVS's Anafranil clomipramine to treat depression and obsessive compulsive disorder, and Restoril temazepam for transient and short-term insomn...